Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support in New Era of Heart Transplant
Heart failure is a serious and challenging medical condition characterized by the inability of the heart to pump blood effectively, leading to reduced blood flow to organs and tissues. Several underlying causes may be linked to this, including coronary artery disease, hypertension, or previous heart...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Transplant International |
| Subjects: | |
| Online Access: | https://www.frontierspartnerships.org/articles/10.3389/ti.2024.12981/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850113998827028480 |
|---|---|
| author | Lorenzo Giovannico Giuseppe Fischetti Domenico Parigino Luca Savino Nicola Di Bari Aldo Domenico Milano Massimo Padalino Tomaso Bottio |
| author_facet | Lorenzo Giovannico Giuseppe Fischetti Domenico Parigino Luca Savino Nicola Di Bari Aldo Domenico Milano Massimo Padalino Tomaso Bottio |
| author_sort | Lorenzo Giovannico |
| collection | DOAJ |
| description | Heart failure is a serious and challenging medical condition characterized by the inability of the heart to pump blood effectively, leading to reduced blood flow to organs and tissues. Several underlying causes may be linked to this, including coronary artery disease, hypertension, or previous heart attacks. Therefore, it is a chronic condition that requires ongoing management and medical attention. HF affects >64 million individuals worldwide. Heart transplantation remains the gold standard of treatment for patients with end-stage cardiomyopathy. The recruitment of marginal donors may be considered an asset at the age of cardiac donor organ shortage. Primary graft dysfunction (PGD) is becoming increasingly common in the new era of heart transplantations. PGD is the most common cause of death within 30 days of cardiac transplantation. Mechanical Circulatory Support (MCS), particularly venoarterial extracorporeal membrane oxygenation (V-A ECMO), is the only effective treatment for severe PGD. VA-ECMO support ensures organ perfusion and provides the transplanted heart with adequate rest and recovery. In the new era of heart transplantation, early use allows for increased patient survival and careful management reduces complications. |
| format | Article |
| id | doaj-art-31d8317cf8c24958bbbdb41c46d97ccf |
| institution | OA Journals |
| issn | 1432-2277 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Transplant International |
| spelling | doaj-art-31d8317cf8c24958bbbdb41c46d97ccf2025-08-20T02:37:01ZengFrontiers Media S.A.Transplant International1432-22772024-12-013710.3389/ti.2024.1298112981Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support in New Era of Heart TransplantLorenzo GiovannicoGiuseppe FischettiDomenico PariginoLuca SavinoNicola Di BariAldo Domenico MilanoMassimo PadalinoTomaso BottioHeart failure is a serious and challenging medical condition characterized by the inability of the heart to pump blood effectively, leading to reduced blood flow to organs and tissues. Several underlying causes may be linked to this, including coronary artery disease, hypertension, or previous heart attacks. Therefore, it is a chronic condition that requires ongoing management and medical attention. HF affects >64 million individuals worldwide. Heart transplantation remains the gold standard of treatment for patients with end-stage cardiomyopathy. The recruitment of marginal donors may be considered an asset at the age of cardiac donor organ shortage. Primary graft dysfunction (PGD) is becoming increasingly common in the new era of heart transplantations. PGD is the most common cause of death within 30 days of cardiac transplantation. Mechanical Circulatory Support (MCS), particularly venoarterial extracorporeal membrane oxygenation (V-A ECMO), is the only effective treatment for severe PGD. VA-ECMO support ensures organ perfusion and provides the transplanted heart with adequate rest and recovery. In the new era of heart transplantation, early use allows for increased patient survival and careful management reduces complications.https://www.frontierspartnerships.org/articles/10.3389/ti.2024.12981/fullheart transplantheart failureprimary graft dysfunctionECMOheart disease |
| spellingShingle | Lorenzo Giovannico Giuseppe Fischetti Domenico Parigino Luca Savino Nicola Di Bari Aldo Domenico Milano Massimo Padalino Tomaso Bottio Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support in New Era of Heart Transplant Transplant International heart transplant heart failure primary graft dysfunction ECMO heart disease |
| title | Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support in New Era of Heart Transplant |
| title_full | Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support in New Era of Heart Transplant |
| title_fullStr | Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support in New Era of Heart Transplant |
| title_full_unstemmed | Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support in New Era of Heart Transplant |
| title_short | Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support in New Era of Heart Transplant |
| title_sort | veno arterial extracorporeal membrane oxygenation va ecmo support in new era of heart transplant |
| topic | heart transplant heart failure primary graft dysfunction ECMO heart disease |
| url | https://www.frontierspartnerships.org/articles/10.3389/ti.2024.12981/full |
| work_keys_str_mv | AT lorenzogiovannico venoarterialextracorporealmembraneoxygenationvaecmosupportinneweraofhearttransplant AT giuseppefischetti venoarterialextracorporealmembraneoxygenationvaecmosupportinneweraofhearttransplant AT domenicoparigino venoarterialextracorporealmembraneoxygenationvaecmosupportinneweraofhearttransplant AT lucasavino venoarterialextracorporealmembraneoxygenationvaecmosupportinneweraofhearttransplant AT nicoladibari venoarterialextracorporealmembraneoxygenationvaecmosupportinneweraofhearttransplant AT aldodomenicomilano venoarterialextracorporealmembraneoxygenationvaecmosupportinneweraofhearttransplant AT massimopadalino venoarterialextracorporealmembraneoxygenationvaecmosupportinneweraofhearttransplant AT tomasobottio venoarterialextracorporealmembraneoxygenationvaecmosupportinneweraofhearttransplant |